Prednisone monotherapy is an option for patients with AIH when treatment is expected to last for less than 6 months (suspected drug-induced AIH-like injury), or when azathioprine is contraindicated due to intolerance or complete TPMT deficiency [3]. This evidence concerns the gene TPMT and autoimmune hepatitis.